Annual CFF
-$1.55 M
-$103.26 M-101.53%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual cash flow from financing activities is currently -$1.55 million, with the most recent change of -$103.26 million (-101.53%) on 31 December 2023. During the last 3 years, it has fallen by -$4.44 million (-153.79%). ACRV annual CFF is now -101.38% below its all-time high of $112.22 million, reached on 31 December 2021.ACRV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$1.50 M
-$124.85 M-101.22%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly cash flow from financing activities is currently -$1.50 million, with the most recent change of -$124.85 million (-101.22%) on 30 September 2024. Over the past year, it has dropped by -$1.58 million (-2028.21%). ACRV quarterly CFF is now -101.22% below its all-time high of $123.35 million, reached on 30 June 2024.ACRV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$119.66 M
-$1.58 M-1.30%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock TTM cash flow from financing activities is currently $119.66 million, with the most recent change of -$1.58 million (-1.30%) on 30 September 2024. Over the past year, it has increased by +$17.35 million (+16.95%). ACRV TTM CFF is now -1.30% below its all-time high of $121.25 million, reached on 30 June 2024.ACRV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.5% | -2028.2% | +16.9% |
| 3 y3 years | -153.8% | - | - |
| 5 y5 years | - | - | - |
ACRV Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -101.4% | at low | -101.2% | +25.2% | -1.3% | +7033.0% |
| 5 y | 5 years | -101.4% | at low | -101.2% | +25.2% | -1.3% | +7033.0% |
| alltime | all time | -101.4% | at low | -101.2% | +25.2% | -1.3% | +7033.0% |
Acrivon Therapeutics Common Stock Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.50 M(-101.2%) | $119.66 M(-1.3%) |
| June 2024 | - | $123.35 M(<-9900.0%) | $121.25 M(-7124.6%) |
| Mar 2024 | - | -$172.00 K(-91.4%) | -$1.73 M(+11.1%) |
| Dec 2023 | -$1.55 M | -$2.01 M(-2678.2%) | -$1.55 M(-101.5%) |
| Sept 2023 | - | $78.00 K(-79.4%) | $102.32 M(+0.2%) |
| June 2023 | - | $379.00 K(>+9900.0%) | $102.10 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $0.00(-100.0%) | $101.71 M(0.0%) |
| Dec 2022 | $101.71 M(-9.4%) | $101.86 M(<-9900.0%) | $101.71 M(<-9900.0%) |
| Sept 2022 | - | -$140.00 K(+1172.7%) | -$151.00 K(+1272.7%) |
| June 2022 | - | -$11.00 K(<-9900.0%) | -$11.00 K(<-9900.0%) |
| Mar 2022 | - | $0.00 | $0.00 |
| Dec 2021 | $112.22 M(+3784.4%) | - | - |
| Dec 2020 | $2.89 M | - | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual cash flow from financing activities?
- What is the all time high annual CFF for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual CFF year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly CFF year-on-year change?
- What is Acrivon Therapeutics Common Stock TTM cash flow from financing activities?
- What is the all time high TTM CFF for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock TTM CFF year-on-year change?
What is Acrivon Therapeutics Common Stock annual cash flow from financing activities?
The current annual CFF of ACRV is -$1.55 M
What is the all time high annual CFF for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual cash flow from financing activities is $112.22 M
What is Acrivon Therapeutics Common Stock annual CFF year-on-year change?
Over the past year, ACRV annual cash flow from financing activities has changed by -$103.26 M (-101.53%)
What is Acrivon Therapeutics Common Stock quarterly cash flow from financing activities?
The current quarterly CFF of ACRV is -$1.50 M
What is the all time high quarterly CFF for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly cash flow from financing activities is $123.35 M
What is Acrivon Therapeutics Common Stock quarterly CFF year-on-year change?
Over the past year, ACRV quarterly cash flow from financing activities has changed by -$1.58 M (-2028.21%)
What is Acrivon Therapeutics Common Stock TTM cash flow from financing activities?
The current TTM CFF of ACRV is $119.66 M
What is the all time high TTM CFF for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high TTM cash flow from financing activities is $121.25 M
What is Acrivon Therapeutics Common Stock TTM CFF year-on-year change?
Over the past year, ACRV TTM cash flow from financing activities has changed by +$17.35 M (+16.95%)